Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00790803 · ClinicalTrials.gov registry record · NA
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
A NA study, sponsored by Wake Forest University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00790803: Completed NA study, sponsored by Wake Forest University.
NCT00790803 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00790803, a NA study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
According to a recent estimate more than 280,000 people in the United States are affected by uveitis each year. This report, also estimated that uveitis is the reason for 30,000 new cases of blindness/year and up to 10 percent of all cases of blindness. The purpose of this trial is to determine the effectiveness of VEGF blockade with intravitreal pegaptanib in patients with uveitic CME.
Primary Outcome
The primary outcome was an improvement in VA greater than or equal to fifteen letters on the EDTRS chart.
Interventions
- DRUG Pegaptanib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT00790803 record still lists
NCT00790803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Pegaptanib is the first listed.
NCT00790803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00790803 about?
NCT00790803 is a clinical study titled "Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema". According to a recent estimate more than 280,000 people in the United States are affected by uveitis each year. This report, also estimated that uveitis is the reason for 30,000 new cases of blindness/year and up to 10 percent of all cases of blindness. The purpose of this trial is to determine the ...
What is the current status of trial NCT00790803?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2009-03. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00790803?
The interventions under investigation include: Pegaptanib (DRUG).
Who is sponsoring clinical trial NCT00790803?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00790803's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia